News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EDP Biotech Corporation Begins Early Commercialization Process During Medica Trade Fair


11/24/2010 9:34:18 AM

KNOXVILLE, Tenn.--(BUSINESS WIRE)--EDP Biotech, U.S.-based developer of ColoMarker™, an innovative blood test to detect the early stages of colon cancer, has begun its global rollout and early commercialization process. The ColoMarker™ test was previewed during Germany’s 2010 Medica Trade Fair.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES